Stay updated on Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page.

Latest updates to the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe webpage has been updated to include new information about a clinical trial for squamous-cell lung cancer, specifically the SQUINT-FoRT 04 trial, and has removed extensive details about non-small-cell lung cancer. The revision number has also been updated.SummaryDifference45%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check84 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check99 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page.